Coppell Rebello Neg
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Blake | 1 | Charlotte Latin EL | David McGinnis |
|
|
| |
| Blake | 4 | Minnetonka SS | Gruber, Ursula |
|
|
| |
| Glenbrooks | 2 | Marlborough JK | Hilligoss, Derek |
|
|
| |
| Glenbrooks | 3 | Westwood PM | Coln, Kassie |
|
|
| |
| Glenbrooks | 5 | Brookfield East DJ | Forrest, Jayanne |
|
|
| |
| Glenbrooks | 7 | Immaculate Heart MF | Gilbert, Colton |
|
|
| |
| Grapevine | 2 | Newman Smith VY | Vijayan, Pranav |
|
|
| |
| Grapevine | 4 | Presentation NR | Salazar, Davd |
|
|
| |
| Grapevine | 5 | Cooper City NR | Bukowsky, Holden |
|
|
| |
| Hockaday | 2 | Viewmont PN | Whisenhunt, Toby |
|
|
| |
| Hockaday | 3 | Byron Nelson PM | Bukowsky, Holden |
|
|
| |
| Hockaday | Octas | McNeil AG | Jones, Lawrence |
|
|
| |
| Important Info | Finals | NA | NA |
|
| ||
| Longhorn Classic | 1 | Greenhill | Georges, Joseph |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Blake | 1 | Opponent: Charlotte Latin EL | Judge: David McGinnis 1ac - queer |
| Blake | 4 | Opponent: Minnetonka SS | Judge: Gruber, Ursula 1ac - stock lay |
| Glenbrooks | 2 | Opponent: Marlborough JK | Judge: Hilligoss, Derek 1ac - prision worksers |
| Glenbrooks | 3 | Opponent: Westwood PM | Judge: Coln, Kassie 1ac - Egypt |
| Glenbrooks | 5 | Opponent: Brookfield East DJ | Judge: Forrest, Jayanne 1AC - Kant 2 Util Advs |
| Glenbrooks | 7 | Opponent: Immaculate Heart MF | Judge: Gilbert, Colton 1ac - heg |
| Grapevine | 2 | Opponent: Newman Smith VY | Judge: Vijayan, Pranav 1ac - queer aff |
| Grapevine | 4 | Opponent: Presentation NR | Judge: Salazar, Davd 1ac amazing |
| Grapevine | 5 | Opponent: Cooper City NR | Judge: Bukowsky, Holden 1ac - communism |
| Hockaday | 2 | Opponent: Viewmont PN | Judge: Whisenhunt, Toby 1ac - no spread stock |
| Hockaday | 3 | Opponent: Byron Nelson PM | Judge: Bukowsky, Holden 1ac - stock on their disco |
| Hockaday | Octas | Opponent: McNeil AG | Judge: Jones, Lawrence 1ac - phil |
| Longhorn Classic | 1 | Opponent: Greenhill 1ac - germany |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
0 - Contact InfoTournament: Important Info | Round: Finals | Opponent: NA | Judge: NA If you need to contact me for any reason: Cell: (469)-496-1009Personal Email: eamorebellion@gmail.comSchool Email (Only use if no response): ear3564@g.coppellisd.comCell is preferredI check both my cell and my personal email frequently during tournaments. My school email may work, but outside emails may be blocked. I try to check daily else-wise. If you text me, please preface it with your name and the fact we are about to debate.I don't want to miss it or mark it as spam | 9/9/21 |
0 - Description of MeTournament: Important Info | Round: Finals | Opponent: NA | Judge: NA I primarily use Google Docs to share files, but if you ask in round I can give you any other format that you can download from google docs (.docx, .pdf) I will send the link to the aforementioned google doc in the chat. I will most likely let you keep viewing access to the doc till the end of time, or at least until the tournament ends, which is more than enough for you to download it. I use common sense trigger warnings, but again, contact me if you want me to add more to my speech. | 9/9/21 |
0 - NavigationTournament: Important Info | Round: Finals | Opponent: NA | Judge: NA Date/Arg will be the format Date Range0 - Important Wiki Stuff Arg TypeT - Topicality | 9/9/21 |
JF - Digital Divide DATournament: Blake | Round: 4 | Opponent: Minnetonka SS | Judge: Gruber, Ursula | 12/19/21 |
JF - Queer Futurism DATournament: Blake | Round: 1 | Opponent: Charlotte Latin EL | Judge: David McGinnis | 12/18/21 |
ND Cap K v1Tournament: Glenbrooks | Round: 7 | Opponent: Immaculate Heart MF | Judge: Gilbert, Colton | 11/21/21 |
ND Cap K v2 T SPECTournament: Longhorn Classic | Round: 1 | Opponent: Greenhill | 12/3/21 |
ND T a Cap K v2Tournament: Glenbrooks | Round: 3 | Opponent: Westwood PM | Judge: Coln, Kassie | 11/21/21 |
ND T-Prisoners Abolition KTournament: Glenbrooks | Round: 2 | Opponent: Marlborough JK | Judge: Hilligoss, Derek | 11/20/21 |
ND Teacher - DA Arbitration - CPTournament: Hockaday | Round: 3 | Opponent: Byron Nelson PM | Judge: Bukowsky, Holden | 11/20/21 |
ND-Stock NegTournament: Hockaday | Round: 2 | Opponent: Viewmont PN | Judge: Whisenhunt, Toby | 11/13/21 |
SO - T Nebel Set Col KTournament: Grapevine | Round: 5 | Opponent: Cooper City NR | Judge: Bukowsky, Holden | 11/21/21 |
SO TDA Nebel and Substandard DrugsTournament: Grapevine | Round: 2 | Opponent: Newman Smith VY | Judge: Vijayan, Pranav NEBEL T - Generic Spec2:07 Medicines is a generic bare pluralSaying that you reduce IPR for one medicine doesn't mean you reduce IPR for all medicinesStandardsInfinitely Regressive: There is no threshold for how much the aff can specify. It would kill limits and predictability because there are an infinite number of case combinations available. Paradigm IssuesDrop the Arg Substandard Drugs DABrink: 10 of all drugs in developing countries are substandard; Breman 19Breman, Joel (C. Dr. Breman was educated at the University of California, Los Angeles; Keck School of Medicine, University of Southern California (USC); and the London School of Hygiene and Tropical Medicine. He trained in internal medicine at the USC-Los Angeles County Medical Center, infectious diseases at the Channing Laboratory, Harvard Medical School, and epidemiology at CDC. He is Senior Scientist Emeritus, NIH and President-Elect, the American Society of Tropical Medicine and Hygiene. Dr. Breman worked on smallpox eradication, measles control, and disease surveillance as a CDC assignee to Guinea, Burkina Faso (Upper Volta), and WHO, Geneva. Following the eradication of smallpox, Breman returned to CDC where he worked on malaria treatment, epidemiology and control in Africa. In 1995, he followed his wife, an environmental lawyer, to Washington, DC, to become Director, Program in Emerging Infectious Diseases, Fogarty International Center, NIH.). "It's time to stop murder by counterfeit medicine." STAT, 2019, May 7, https://www.statnews.com/2019/05/07/stopping-murder-counterfeit-medicine/ Accessed 30 Aug. 2021. Link: IP protections are a essential barrier to fight counterfeit medicine and substandard drugs; Lybecker, 16Lybecker, Kristina M (C. Dr. Kristina M. Lybecker is an Associate Professor of Economics at Colorado College in Colorado Springs, where she is also the Associate Chair of the Department of Economics and Business and the Gerald L. Schlessman Professor of Economics. She has testified numerous times on the economics of the importation of Canadian drugs and the risks of pharmaceutical counterfeiting. Dr. Lybecker has also worked with US Food and Drug Administration, PhRMA, and the World Bank, on a variety of issues relating to the economics of innovation and international trade policies.) "Counterfeit Medicines and the Role of IP in Patient Safety." IPWatchdog.com | Patents andamp; Patent Law, IPWatchdog, 27 June 2016, www.ipwatchdog.com/2016/06/27/counterfeit-medicines-ip-patient-safety/id=70397/. Internal Link: Lack of IP floods markets with dangerous products; Mercurio, 21Mercurio, Bryan (C.Bryan Mercurio is the Simon F.S. Li Professor of Law at the Chinese University of Hong Kong (CUHK), having served as Associate Dean (Research) from 2010-14 and again from 2017-19. Professor Mercurio specialises in international economic law (IEL), with particular expertise in the intersection between trade law and intellectual property rights, free trade agreements, trade in services, dispute settlement and increasingly international investment law.) "The IP Waiver for COVID-19: Bad Policy, Bad Precedent." IIC; international review of industrial property and copyright law, 1-6. 24 Jun. 2021, doi:10.1007/s40319-021-01083-5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223179/ | 9/11/21 |
SO TH F Extra-topicality FramingTournament: Grapevine | Round: 4 | Opponent: Presentation NR | Judge: Salazar, Davd Interp – The affirmative may only claim offense from reduce intellectual property protections for medicinesViolation – they defend abolishing all intellectual property protections, not just the ones applicable to medicinesVote neg – on extra T. Two net benefits. TVA: defend abolition of medical patents.Cross apply paradigm issues. Paradigm IssuesDrop the Debater: A loss deters future abuse The role of the ballot is to evaluate the desirability of the consequences of a topical plan. Prefer—~1~ Weighability—scenarios can be weighed through impact calc, but resistance methods can't vecause you can't weigh opposition to structures of inequality—that freezes actions because there's no way to decide between multiple actions Evaluating consequences is good—creates meaningful discussion instead of hostile exchangeBracey 06, Christopher A ~Christopher Alan Bracey is an American law professor and former litigator. In 2017, he serves as a law professor at the George Washington University Law School and Vice Provost for Faculty Affairs at the George Washington University. He is a leading scholar on race, inequality, and the law.~. "The Cul De Sac of Race Preference Discourse." SSRN Scholarly Paper. Rochester, NY: Social Science Research Network, September 1, 2006. https://papers.ssrn.com/abstract=2018352.~~Anop That is the only egalitarian metric—-anything else collapses cooperation on collective action crises and makes extinction inevitableKhan 18 (Risalat, activist and entrepreneur from Bangladesh passionate about addressing climate change, biodiversity loss, and other existential challenges. He was featured by The Guardian as one of the "young climate campaigners to watch" (2015). As a campaigner with the global civic movement Avaaz (2014-17), Risalat was part of a small core team that spearheaded the largest climate marches in history with a turnout of over 800,000 across 2,000 cities. After fighting for the Paris Agreement, Risalat led a campaign joined by over a million people to stop the Rampal coal plant in Bangladesh to protect the Sundarbans World Heritage forest, and elicited criticism of the plant from Crédit Agricolé through targeted advocacy. Currently, Risalat is pursuing an MPA in Environmental Science and Policy at Columbia University as a SIPA Environmental Fellow, "5 reasons why we need to start talking about existential risks," https://www.weforum.org/agenda/2018/01/5-reasons-start-talking-existential-risks-extinction-moriori/) The pharmaceutical industry is more powerful than you think – they'll privatize the modern nation-state before losing their patentsPreciado 08. Paul Preciado (Spanish philosopher, queer theorist, and king), 2008, "Testo Junkie," translated by Bruce Benderson, I have a pdf, if you need it, sean!Contemporary biodrag activism is confronted, fifty years after Agnes, with a new set of violent neoliberal economic and politic strategies, including the privatization of the health system, government deregulation, deep cuts in social spending, and the militarization of social life. In the present context, it's possible to imagine (at least) two tracks of development for the pharmacopornographic economy in the face of which different modes of activism could be articulated. The first is the preservation of theological-humanist political states that regulate the action of the neoliberal (meaning free trade, either democratic or totalitarian in the context of globalization) pharmacopornographic economy. Current pharmacopornographic corporations would function as free market tentacles inside contemporary nation-states (which would continue to see themselves as sovereign and patriarchal) and would negotiate with them to determine the directives for the production, use, and consumption of chemical prostheses and semiotic gender and sex codes. The second transformation is one into an abstract deterritorialized nation-state of the pharmacopornographic industry. We could also be witnessing a process of privatization of contemporary nation-states, which would be progressively absorbed by the pharmacopornographic industry. This would be the strategy employed by the pharmacopornographic companies to escape pre-1970s regulations imposed by states (to avoid the gradual transformation of pharmaceutical patents into generics, the more or less severe regulation of the production and distribution of pornographic audiovisual material, and attempts to abolish prostitution), as these companies engage in the political direction of new national entities (via the FDA; the International Monetary Fund; the European Union; and the governments of the United States, China, or India) and purchase state institutions (for example, the Department of Health or Department of Justice or the prison-industrial complex) and put them to work to their benefit, refilling such archaic institutions with new content whose only objective would be increasing consumption and pharmacopornographic profits.The 1AC's analysis of colonial capitalism to demand resistance to research results in nothing but reductionist knowledge production which reduces the nuances of class differences and collapses the complexities created by racial capitalism down to a settler/indigenous binary which creates ineffective resistance by fracturing solidarity and collective bonds between workers. | 9/11/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
12/18/21 | eamorebellion@gmailcom |
| |
12/19/21 | eamorebellion@gmailcom |
| |
11/20/21 | eamorebellion@gmailcom |
| |
11/21/21 | eamorebellion@gmailcom |
| |
11/21/21 | eamorebellion@gmailcom |
| |
11/21/21 | eamorebellion@gmailcom |
| |
9/11/21 | eamorebellion@gmailcom |
| |
9/11/21 | eamorebellion@gmailcom |
| |
11/21/21 | eamorebellion@gmailcom |
| |
11/13/21 | eamorebellion@gmailcom |
| |
11/20/21 | eamorebellion@gmailcom |
| |
11/20/21 | eamorebellion@gmailcom |
| |
12/3/21 | eamorebellion@gmailcom |
|